Drug breakthrough for children with severe form of epilepsy
Zorevunersen, a new spinal infusion drug, dramatically reduces seizures in children with Dravet syndrome by targeting the faulty SCN1A gene underlying the condition.
Drug breakthrough for children with severe form of epilepsy
Zorevunersen, a new spinal infusion drug, dramatically reduces seizures in children with Dravet syndrome by targeting the faulty SCN1A gene underlying the condition.
Mass. girl recovering from rare, serious illness linked to flu
A 4-year-old developed acute necrotizing encephalopathy from influenza, a rare, potentially deadly condition causing rapid brain swelling and possible lasting brain damage.
